MarketsStocksBIOGEN
BI

Biogen Pharmachem Industries Ltd

NSE: BIOGEN BSE: 531752Financial Services
Download Research Report7-page PDF
0.34
+0.00%
NSE · auto-updates while market open
Mkt Cap
₹31 Cr
P / E
32.0
P / B
0.3
ROE
1.0%
52W High
₹0.93
52W Low
₹0.32
Key Metrics
Market Cap
₹31 Cr
P / E
31.97
P / B
0.31
EV / EBITDA
31.74
ROCE
1.0%
ROE
1.0%
Debt / Equity
0.00
Book Value
₹1.10
EPS
₹0.01
Div Yield
0.0%
Face Value
₹1
Promoter Holding
-
Revenue · ₹ Cr
0
FY20
2
FY21
2
FY22
1
FY23
2
FY24
1
FY25
3
FY26
Net Profit · ₹ Cr
0
2
1
0
-2
0
0
FY20FY21FY22FY23FY24FY25FY26
EPS · ₹ per share
₹0.0
₹0.0
₹-1.0
₹-0.0
FY19FY21FY23FY26
Cash Flow Trend · ₹ Cr
1
1
FY22
2
2
FY23
2
2
FY24
−1
−1
FY25
2
2
FY26
Operating cash flowFree cash flow (CFO − capex)Cash conversion: CFO = 186% of net profit (5y)
Q4 '23 snapshot
Sales
₹-1.00L Cr
Operating profit
₹-0 Cr
OPM
1968.0%
Net profit
₹-0 Cr
EPS
-
Scorecard · 7 axes
Quality
Avg
48/100
Valuation
Avg
32.0×
Growth
Weak
+2.1%
Profitability
Bad
1.0%
Performance
Bad
-58.5%
Entry Point
Strong
37%
Red Flags
Strong
0 flags
Shareholding Pattern
100.0%Public
Public100.0%
Quarterly Results · ₹ Cr
QuarterQ3 '20Q4 '20Q1 '21Q2 '21Q3 '22Q4 '23
Revenue00002,87,000-1,00,000
Net Profit-95,000-8,70,000-15,000-9,0001,08,000-0.197
NPM %----37.6%0.0%
AlertPre-trade